Hey bavarian1975, Thanks for posting IMU's roadmap through to mid 2025. There is obviously heaps of news and developments on the way. I counted 14, covering the three studies- azer-cel - onCARlytics - VAXINIA. Most if not all, would be worthy of a price sensitive announcement when they drop !
Footmax dose a great job bringing us up to date, with overnight trade every day. The Dow got whacked on Friday night, as nervousness over Trump and the effects of a new administration, has American's nervous. IMU might be one of the few green stocks on the ASX today, as I doubt anyone would want to dump their shares in IMU, based on one nights trading. The sellers last week seem to have dried up, with a small dip later in the week as short term profit takers swept up their 20% gains over recent weeks.
The other positive for me, is that whilst IMU gained enough funding to see out most of this year on December 23rd. But that's exactly what it is- enough for this year. Whilst we've been educated by the Bio educated, that studies take time, they've now had enough time with data being pushed back twice, over 9 months now. Be it good - bad or expensive to produce, it's coming. The people conducting such studies would want to be paid, whilst once in receipt IMU has a responsibility to produce.
All of the above is why MaNipulaTor's have been drying up, so as they don't get whacked again like in November of 2023. It's also in IMU's management's favor to see a buoyant share price, as soon as possible this year, as they will need capital and either investors or partners by mid year. Leslie has been very quite since dragging Yuman Fong into one of her promotional interviews, last November. Forget the season, for mine her being this quite for so long tells me there's been bigger thing's brewing. Let's see what they roll out over the coming days and weeks !
Hang in there !
-GO IMU!
Not Financial Advice - Opinions Only - DYOR!
IMU Price at posting:
4.3¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)